Akèy › Kansè tete negatif triple › New Jersey › Edison
Etid klinik pou Kansè tete negatif triple nan Edison, NJ
11 etid pou Kansè tete negatif triple ap chèche patisipan nan sit nan ak bò kote Edison (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.
Tèks ofisyèl etid la (Anglè)
Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →
A Phase 1 Study of PLN-101095 in Adults With Advanced or Metastatic Solid Tumors
Ap rekriteFaz 1
- START New Jersey, East Brunswick · 6 mi lwen
Multicenter Trial for Eliminating Breast Cancer Surgery or Radiotherapy in Exceptional Responders to Neoadjuvant Systemic Therapy
Ap rekrite
- Cooper Hospital Univ Med Ctr, MD Anderson at Cooper Voorhees, Voorhees Township · 5 mi lwen
A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)
Ap rekriteFaz 3
- Rutgers Cancer Institute of New Jersey ( Site 0076), New Brunswick · 3 mi lwen
A Study of Pembrolizumab and Ablation (Cryoablation or Histotripsy) in People With Breast Cancer
Ap rekriteFaz 1
- Memorial Sloan Kettering Cancer Center at Basking Ridge (Limited Protocol Activities), Basking Ridge · 15 mi lwen
A Study of SDX-7320 in Combination With Eribulin for People With Breast Cancer
Ap rekriteFaz 2
- Memorial Sloan Kettering Basking Ridge (All Protocol Activities), Basking Ridge · 15 mi lwen
Study of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physician's Choice in Patients With Triple Negative Breast Cancer Who Have Residual Invasive Disease After Surgery and Neoadjuvant Therapy (ASCENT-05/AFT-65 OptimICE-RD/GBG 119/NSABP B-63)
Ap rekriteFaz 3
- Rutgers Health, New Brunswick · 3 mi lwen
- Regional Cancer Care Associates LLC, East Brunswick · 6 mi lwen
A Study of Cyclophosphamide, Methotrexate, Fluorouracil (CMF) for People With Breast Cancer
Ap rekriteFaz 2
- Memorial Sloan Kettering at Basking Ridge (Limited Protocol Activities), Basking Ridge · 15 mi lwen
I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast Cancer
Ap rekriteFaz 2
- Rutgers Cancer Institute of New Jersey, New Brunswick · 3 mi lwen
Investigating the Effectiveness of Stereotactic Body Radiotherapy (SBRT) in Addition to Standard of Care Treatment for Cancer That Has Spread Beyond the Original Site of Disease
Ap rekriteFaz 2
- Memorial Sloan Kettering Basking Ridge, Basking Ridge · 15 mi lwen
A Study of Radiation Therapy With Pembrolizumab and Olaparib or Other Radiosensitizers in Women Who Have Triple-Negative or Hormone-Receptor Positive/Her2 Negative Breast Cancer
Ap rekriteFaz 2
- Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities), Basking Ridge · 15 mi lwen
A Phase 2 Study of PCS6422 With Capecitabine in Patients With Advanced or Metastatic Breast Cancer
Ap rekriteFaz 2
- Rutgers Cancer Institute of New Jersey, New Brunswick · 3 mi lwen
Etid Kansè tete negatif triple nan lòt vil
- Houston, TX42 etid
- New York City, NY31 etid
- Nashville, TN28 etid
- Los Angeles, CA27 etid
- Boston, MA26 etid
- San Antonio, TX23 etid
- St. Louis, MO21 etid
- Arlington, VA20 etid
- Atlanta, GA20 etid
- Dallas, TX18 etid
- Chicago, IL16 etid
- Columbus, OH16 etid
Lòt etid nan Edison
- Kansè nan tete68 etid
- Kansè Poumon ki pa ti selil47 etid
- Kansè (tout kalite)33 etid
- Kansè pwostat29 etid
- Kansè kolorektal23 etid
- Kansè poumon23 etid
- Myelom Miltip22 etid
- Kansè vejik21 etid
- Leksemi mieloïd egi20 etid
- Kansè ovè20 etid
- Kansè Metastatik20 etid
- Kansè Endomèt19 etid
Sous ClinicalTrials.gov, done yo ranmase Oct 6, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.